Prodrugs for Targeted Tumor Therapies: Recent Developments in ADEPT, GDEPT and PMT

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|32|3527-3547

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.32, 2011-11, pp. : 3527-3547

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Developments of Targeted Therapies in the Treatment of Non-Small Cell Lung Cancer

By  

Current Drug Discovery Technologies, Vol. 6, Iss. 2, 2009-06 ,pp. : 91-102

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Therapies in Breast Cancer: Established Drugs and Recent Developments

By  

Current Clinical Pharmacology, Vol. 3, Iss. 2, 2008-05 ,pp. : 85-98

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Tumor Therapies at a Glance

By  

Current Drug Targets, Vol. 10, Iss. 2, 2009-02 ,pp. : 89-93

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticles for Tumor Targeted Therapies and Their Pharmacokinetics

By  

Current Drug Metabolism, Vol. 11, Iss. 2, 2010-02 ,pp. : 129-141

Bentham Science Publishers

Access to resources Recommend Favorite

Anticancer Prodrugs: An Overview of Major Strategies and Recent Developments

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 18, 2011-09 ,pp. : 2346-2381

Bentham Science Publishers

Access to resources Recommend Favorite